spacer
home > pmps > autumn 2008 > lean machine
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Lean Machine

Pharmaceutical manufacturing costs the industry approximately $90 billion each year and represents twice the expenditure of R&D (1). A 2001 study conducted by the MIT Pharmaceutical Manufacturing Initiative (PHARMI) indicated that significant time was spent conducting quality control (QC) testing and documenting QC results during the manufacturing process (2). Eroding profit margins from stiff competition, increasing product defects, and the FDA’s focus on a ‘quality by design model’ has led the industry to reevaluate manufacturing efficiency (1,3). The industry has recently begun adopting both lean manufacturing and Six Sigma to achieve the efficiency and quality gains achieved by other industries (4-6). IT solutions will play a significant role in managing QC standard operating procedure (SOP) documentation during the focus on lean and Six Sigma to eliminate waste, improve...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Chris Stumpf joined Waters in 2001 after earning his PhD in Analytical Chemistry and Mass Spectrometry from Purdue University in 2000, and held a post doctoral position at the University of Cincinnati Medical School conducting proteomics research. During his doctorate and post-doctorate education, he became keenly interested in informatics solutions to manage and mine analytical data.

Phil Kilby joined Waters in 1998. He received a degree in Chemistry from Greenwich University while working in drug metabolism at Rhone Poulenc in London. He is now responsible for worldwide business and partnership development of Waters’ suite of informatics solutions. Email: phil_kilby@waters.com

spacer
Chris Stumpf
spacer
spacer
spacer
Phil Kilby
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals enters into manufacturing agreement with the Swedish company Affibody

[Noáin, May 27, 2019] 3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufacturing of biologics, has signed a collaboration agreement with the Swedish company Affibody for the process transfer, scale-up and GMP commercial manufacturing of a recombinant protein sole property of Affibody.
More info >>

White Papers

Personalised Medicine - Pharma and Dx Firms Share Wider Horizons

DiagnostikNet-BB

Personalised medicine might be a popular catch-phrase at the moment, but the term often causes confusion, as there is still no uniform definition for it. The expression can include areas as diverse as the measurement of individual risk, early detection using biomarker testing, stratification of patients suffering from a disease and predictions about its course.
More info >>

 
Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement